These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8805563)

  • 21. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.
    Cello J; Paul AV; Wimmer E
    Science; 2002 Aug; 297(5583):1016-8. PubMed ID: 12114528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
    Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
    Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poliovirus mutants resistant to neutralization with soluble cell receptors.
    Kaplan G; Peters D; Racaniello VR
    Science; 1990 Dec; 250(4987):1596-9. PubMed ID: 2177226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poliovirus and apoptosis.
    Blondel B; Couderc T; Simonin Y; Gosselin AS; Guivel-Benhassine F
    Prog Mol Subcell Biol; 2004; 36():151-69. PubMed ID: 15171611
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
    Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F
    Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model for the differential stabilities of rhinovirus and poliovirus to mild acidic pH, based on electrostatics calculations.
    Warwicker J
    J Mol Biol; 1992 Jan; 223(1):247-57. PubMed ID: 1309885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two determinants in the capsid of a persistent type 3 poliovirus exert different effects on mutant virus uncoating.
    Duncan G; Colbère-Garapin F
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2601-2605. PubMed ID: 10573152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-receptor interaction in poliovirus entry and pathogenesis.
    Racaniello VR
    Harvey Lect; 1991-1992; 87():1-16. PubMed ID: 1670545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipoliovirus activity of isothiazole derivatives: mode of action of 5,5'-diphenyl-3,3'-diisothiazole disulfide (DID).
    Garozzo A; Pinizzotto MR; Guerrera F; Tempera G; Castro A; Geremia E
    Arch Virol; 1994; 135(1-2):1-11. PubMed ID: 8198435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase.
    Pelletier I; Duncan G; Pavio N; Colbère-Garapin F
    Cell Mol Life Sci; 1998 Dec; 54(12):1385-402. PubMed ID: 9893712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of poliovirus into the endosomal system of HeLa cells.
    Kronenberger P; Schober D; Prchla E; Ofori-Anyinam O; Vrijsen R; Rombaut B; Blaas D; Fuchs R; Boeyé A
    Arch Virol; 1998; 143(7):1417-24. PubMed ID: 9722884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro synthesis of poliovirus.
    Molla A; Paul AV; Wimmer E
    Dev Biol Stand; 1993; 78():39-53. PubMed ID: 8388831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity.
    Gromeier M; Lu HH; Bernhardt G; Harber JJ; Bibb JA; Wimmer E
    Ann N Y Acad Sci; 1995 May; 753():19-36. PubMed ID: 7611627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
    Dove AW; Racaniello VR
    J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intergeneric poliovirus recombinants for the treatment of malignant glioma.
    Gromeier M; Lachmann S; Rosenfeld MR; Gutin PH; Wimmer E
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6803-8. PubMed ID: 10841575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neurotropism of poliovirus].
    Koike S
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1231-6. PubMed ID: 17824245
    [No Abstract]   [Full Text] [Related]  

  • 37. New (fluorescent) light on poliovirus entry.
    Bergelson JM
    Trends Microbiol; 2008 Feb; 16(2):44-7. PubMed ID: 18191571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-dependent role for the poliovirus 3' noncoding region in positive-strand RNA synthesis.
    Brown DM; Kauder SE; Cornell CT; Jang GM; Racaniello VR; Semler BL
    J Virol; 2004 Feb; 78(3):1344-51. PubMed ID: 14722289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures.
    Pelletier I; Duncan G; Colbère-Garapin F
    Virology; 1998 Feb; 241(1):1-13. PubMed ID: 9454712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poliovirus subviral particles associated with progeny RNA in the replication complex.
    Pfister T; Egger D; Bienz K
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():63-71. PubMed ID: 7844543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.